Medipattern's Medical Imaging B-CAD Product Approved for Sale in China

Toronto-based Medipattern Corporation, a developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making biopsy decisions, announced the receipt of State Food and Drug Administration (SFDA) approval in the China for its B-CAD product. Beijing Eastwide Medical Ltd., Medipattern’s reseller in China, will promote and market B-CAD throughout China. B-CAD is installed and now in daily use at the newly created Breast Imaging Center at the People’s Liberation Army (PLA) 301 Hospital in Beijing. Medical practitioners and technicians will go to the hospital to be trained and certified on the use of B-CAD through a Continuing Medical Education initiative developed by the PLA 301. Beijing Eastwide Medical has more than 20 offices in various provinces throughout China.